Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study (Front. Oncol, (2020), 10, (590707), 10.3389/fonc.2020.590707)

Girolamo Ranieri, Carmelo Laface, Mariarita Laforgia, Simona De Summa, Mariangela Porcelli, Francesco Macina, Michele Ammendola, Pasquale Molinari, Gianfranco Lauletta, Alessandra Di Palo, Giuseppe Rubini, Cristina Ferrari, Cosmo Damiano Gadaleta

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original article, the ethical consideration statement was inserted by error in the section Patients and Methods, sub-section Statistical Analysis, as paragraphs 3 and 4:.

Original languageEnglish
Article number637880
JournalFrontiers in Oncology
Volume10
DOIs
Publication statusPublished - Feb 5 2021

Keywords

  • bevacizumab
  • chemotherapy
  • hyperthermia
  • metastatic colon cancer
  • tumor angiogenesis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study (Front. Oncol, (2020), 10, (590707), 10.3389/fonc.2020.590707)'. Together they form a unique fingerprint.

Cite this